20th International SPECTRALIS Symposium – register now
Join us in Berlin, May 26 - 27, 2023, to celebrate the 20th anniversary of our esteemed International SPECTRALIS Symposium (ISS)!

Join us in Berlin, May 26 - 27, 2023, to celebrate the 20th anniversary of our esteemed International SPECTRALIS Symposium (ISS)!
This journal article highlights the value of SPECTRALIS OCT volume scans in identifying biomarkers of age-related macular degeneration.
Sophia Pathai, MD, PhD, host of the Ophthalmic Innovation Source podcast, caught up with our Head of Corporate Strategy and Managing Director of MSI, Kfir Azoulay, as well as Tosh Vadhia, Managing Director of Heidelberg Engineering UK, to talk about the trends and opportunities in ophthalmology, including OCT-based biomarkers and artificial intelligence.
In this video, Edwin H. Ryan Jr., MD highlights the efficacy of the SPECTRALIS for the imaging of vitreous opacities (floaters).
A study of 50 patients with fibromyalgia and 232 healthy controls reported that the SPECTRALIS spectral-domain OCT was able to differentiate between controls and fibromyalgia patients.
Heidelberg Engineering, an industry partner of the Glaucoma / Myopia OCT Phenotyping Consortium (GMOPC), welcomes the unveiling of the consortium’s official website.
Josephine Evans, a specialist optometrist at the prestigious Moorfields Eye Hospital in London, UK, was honored for her work in exploring the relationship of morphology and function.
The Heidelberg Engineering Extreme Research Award 2022 has been presented to Dr. Bettina Hohberger for her diagnostic insights into long COVID.
The ANTERION® combines biometry with corneal topography and tomography, anterior chamber metrics, and high-resolution OCT imaging in a single, small, workflow efficient device. The ANTERION is a true multi-modality platform, ideally suited to high-throughput cataract clinics and surgical hubs.
A recent study of OCT changes in spaceflight-associated neuro-ocular syndrome (SANS) highlighted in the September 25th issue of Ocular Surgery News suggests that it may be possible for longer-duration lower body negative pressure (LBNP) application to reverse spaceflight-induced ocular changes.